Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Topic:
Thrombosis and platelets
Speaker:
Professor K. Huber (Vienna, AT)
Sponsored by Daiichi Sankyo Europe GmbH
Event:
ESC Congress 2016
Congress Presentation
About the speaker
Professor Kurt Huber
Sigmund Freud University Vienna, FacutlVice Dean of Researchy fo Medicine, Vienna (Austria)
54
presentations
10
followers
3 more presentations in this session
Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speaker: Professor K. Huber (Vienna, AT)
Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
Speaker: Professor J. Jukema (Leiden, NL)
Access the full session
Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speakers:
Professor K. Huber, Professor K. Huber, Professor A. Schaefer, Professor J. Jukema
About the event
ESC 365 is supported by
